Here are five highlights:
1. DUROLANE is a single-injection joint-fluid osteoarthritis treatment based on a natural, safe and proven technology process called NASHA, which yields stabilizing hyaluronic acid.
2. Hyaluronic acid is a naturally occurring molecule that provides the lubrication and cushioning in a normal joint.
3. In Taiwan, DUROLANE is indicated for the treatment of mild to moderate osteoarthritis of the knee.
4. In Taiwan, Bioventus will be working with Eulogiums, a sales and marketing leader with more than 20 years of experience in orthopedics.
5. Bioventus is an orthobiologics company that delivers clinically proven, cost-effective products that help people heal quickly and safely.
More articles on devices and implants:
Zacks bumps RTI Surgical down to “sell” rating: 4 things to know
Eagle Asset Management buys 1.2M+ of NuVasive stock: 4 points
Cardinal Spine files form D for $1.25M in financing: 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
